A randomized clinical trial with two doses of a omega 3 fatty acids oral and arginine enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients.

de Luis, D A; Izaola, O; Cuellar, L; Terroba, M C; de la Fuente, B; Cabezas, G

de Luis, D A; Izaola, O; Cuellar, L; Terroba, M C; de la Fuente, B; Cabezas, G.

Affiliation

de Luis DA; Institute of Endocrinology and Nutrition, Medicine School and Hospital Rio Hortega, University of Valladolid, Valladolid, Spain. dadluis@yahoo.es

Eur Rev Med Pharmacol Sci ; 17(8): 1090-4, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23661523

Subject(s)

Arginine/administration & dosage; Fatty Acids, Omega-3/administration & dosage; Head and Neck Neoplasms/drug therapy; Administration, Oral; Adult; Aged; Female; Head and Neck Neoplasms/blood; Humans; Lymphocyte Count; Male; Middle Aged; Prospective Studies; Serum Albumin/analysis; Transferrin/analysis

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Arginine / Fatty Acids, Omega-3 / Head and Neck Neoplasms Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2013 Document type: Article Affiliation country: Spain Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links